Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HiQ-Nano is an Italian biotechnology company that specializes in the design and production of high-quality nanoparticles for research and diagnostic applications. A spin-off from the Italian Institute of Technology (IIT), the company provides a wide range of monodisperse nanoparticles, including gold, silver, silica, and magnetic particles, with precise control over size and surface chemistry. These products are essential for applications in bio-imaging, drug delivery, and the development of advanced diagnostic assays. HiQ-Nano also offers custom synthesis and functionalization services to support specific academic and industrial research needs. By providing highly standardized nanomaterials, the company enables more reproducible and reliable results in the field of nanomedicine. The company's expertise lies in bridging the gap between fundamental nanotechnology research and its practical implementation in the life sciences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HiQ-Nano.